| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 57.27 | -0.16 (-0.28%) | 39.81 - 64.55 | 642.6 thousand (Below Avg) |
Market data as of 4:02PM 05/16/12. Quotes are delayed by at least 15 min.
| Open | 57.72 |
|---|---|
| Previous Close | 57.43 |
| Day's Range | 57.24 - 57.84 |
| Market Cap | 6.6B |
| Avg Volume (10 Day) | 766.7K |
| Price/Earnings (Trailing 12 Mo.) | 21.0x |
| Earnings Per Share (Trailing 12 Mo.) | 2.74 |
| Dividend Yield | 0.21 (1.47%) |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Fail |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Pass |
| Increased shareholder value? | Pass |
| Consistently increased owner earnings? | Pass |
| Sells at 25% discount to intrinsic value? | Pass |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Pass |
|---|---|
| Room to increase dividends? | Pass |
| Increased earnings over time? | Fail |
| Borrows within reasonable limits? | Pass |
| Stock is undervalued? | Fail |
| Have investors caught on? | Fail |
| Has support of institutional investors? | Pass |
| Has sufficient liquidity? | Pass |
Clinical Study Shows Pall In-line Infusion Filters Reduce Complications in Pediatric ICU Patients
Business Wire - Monday 05/07/2012 4:00 PM ET
Pall GeneDisc® Plates for Listeria Testing Granted AOAC Certification
Business Wire - Friday 05/04/2012 2:00 PM ET
Pall Expands Single-Use Solutions Portfolio with New Products at INTERPHEX 2012
Business Wire - Tuesday 05/01/2012 8:00 AM ET
Pall Announces 10:00 a.m. EDT Webcast on Monday, April 30 to Discuss Agreement to Sell Blood Product Lines
Business Wire - Sunday 04/29/2012 12:49 PM ET
Pall Corporation Signs Definitive Agreement to Sell its Blood Collection, Filtration and Processing Product Lines to Haemonetics for $550 Million
Business Wire - Sunday 04/29/2012 12:00 PM ET
Haemonetics Signs Definitive Agreement to Acquire Pall Corporation's Blood Collection, Filtration and Processing Product Lines For $551 Million
PR Newswire - Sunday 04/29/2012 12:00 PM ET
Pall Corporation Board of Directors Declares Dividend
Business Wire - Thursday 04/19/2012 4:49 PM ET
Pall Corp. to Present Water Treatment Solutions at MiningWorld Russia
Business Wire - Tuesday 04/17/2012 9:01 AM ET
| PLL | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | 13.69% | |
| Net Income Growth (1yr) | 18.73% | |
| Total Debt/Equity | 0.40 | |
| LT Debt/Equity | 0.31 | |
| Earnings Yield | 4.76% | |
| Price/Sales | 2.30 |
| Company | Last | Change |
|---|---|---|
| Flowserve Corp | 107.33 | -1.38% |
| SPX Corp | 72.90 | -3.23% |
| Dresser-Rand Group Inc | 45.68 | -1.19% |
| IDEX Corp | 40.14 | -1.38% |
| Nordson Corp | 50.87 | 0.00% |
Data is delayed by at least 15 min.